IAK ETF Analysis: U.S. Insurance | NYSE
Financials Equity | NYSE, USA | Market Cap: 447m USD | 12M Return: 22% | US4642887867 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.0M
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The iShares U.S. Insurance ETF (IAK) is structured to track its underlying index by investing at least 80% of its assets in the indexs component securities or investments with substantially identical economic characteristics. The remaining portion of the portfolio may be allocated to derivatives such as futures, options, and swap contracts, as well as cash equivalents and securities outside the index when BlackRock Fund Advisors (BFA) believes such holdings will support index tracking. The fund operates as a non-diversified vehicle, meaning it may hold a more concentrated position in fewer issuers compared to diversified funds.
The insurance sector encompasses companies that underwrite policies across life, health, property, casualty, and reinsurance lines, generating revenue primarily through premium collections and returns on invested reserves. As a sector-specific ETF, IAK provides targeted exposure to publicly traded U.S. insurance companies, allowing investors to participate in the industrys performance without purchasing individual stocks.
- Interest rates rise boosting insurer investment income yields
- Catastrophe losses from hurricanes and wildfires pressure underwriting margins
- Hardening commercial insurance pricing improves P&C underwriting profitability
As of November 05, 2026, the stock is trading at USD 149.68 with a total of 70,106 shares traded. Over the past week, the price has changed by +2.20%, over one month by +8.43%, over three months by +2.03% and over the past year by +21.98%.
Current recommended Stop Loss: 147.10 (which is 1.7% or 1.2 ATR below the current price).
U.S. Insurance has no consensus analysts rating.